VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MBI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MBIMBIA Inc.
$6.51$332M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMBIQuarterly Financials

MBIA Inc. (MBI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

MBIA Inc. (MBI) quarterly income statement — complete revenue, gross profit & net income history

MBI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue24M28M15M23M14M37M29M-37M13M-31M8M28M
Revenue Growth %71.43%-24.32%-48.28%162.16%7.69%219.35%262.5%-232.14%550%-154.39%-52.94%-22.22%
Medical Costs & Claims-3M99M-49M9M9M14M12M143M19M21M124M29M
Medical Cost Ratio %-12.5%353.57%-326.67%39.13%64.29%37.84%41.38%-386.49%146.15%-67.74%1550%103.57%
Gross Profit27M-71M64M14M5M23M17M-180M-6M-52M-116M-1M
Gross Margin %112.5%-253.57%426.67%60.87%35.71%62.16%58.62%486.49%-46.15%167.74%-1450%-3.57%
Gross Profit Growth %440%-408.7%276.47%107.78%183.33%144.23%114.66%-17900%0%-171.23%-529.63%-106.67%
Operating Expenses68M-15M71M70M67M73M68M73M81M86M69M77M
OpEx / Revenue %283.33%-53.57%473.33%304.35%478.57%197.3%234.48%-197.3%623.08%-277.42%862.5%275%
Depreciation & Amortization000000000000
Combined Ratio %270.83%300%146.67%343.48%542.86%235.14%275.86%-583.78%769.23%-345.16%2412.5%378.57%
Operating Income-41M-56M-7M-56M-62M-50M-51M-253M-87M-138M-185M-78M
Operating Margin %-170.83%-200%-46.67%-243.48%-442.86%-135.14%-175.86%683.78%-669.23%445.16%-2312.5%-278.57%
Operating Income Growth %33.87%-12%86.27%77.87%28.74%63.77%72.43%-224.36%-4.82%-3350%-428.57%-116.67%
EBITDA6M-8M43M-7M-12M-50M2M-200M-35M-84M-132M-25M
EBITDA Margin %25%-28.57%286.67%-30.43%-85.71%-135.14%6.9%540.54%-269.23%270.97%-1650%-89.29%
Interest Expense47M149M50M49M50M50M53M53M52M54M53M53M
Non-Operating Income-47M-48M-50M-49M-50M0-53M-53M-52M-54M-53M-53M
Pretax Income-41M-56M-7M-56M-62M-50M-51M-253M-87M-138M-185M-78M
Pretax Margin %-170.83%-200%-46.67%-243.48%-442.86%-135.14%-175.86%683.78%-669.23%445.16%-2312.5%-278.57%
Income Tax0-4M0000000000
Effective Tax Rate %0%7.14%0%0%0%0%0%0%0%0%0%0%
Net Income-40M-51M-8M-56M-62M-48M-56M-255M-86M-134M-185M-75M
Net Margin %-166.67%-182.14%-53.33%-243.48%-442.86%-129.73%-193.1%689.19%-661.54%432.26%-2312.5%-267.86%
Net Income Growth %35.48%-6.25%85.71%78.04%27.91%64.18%69.73%-240%0%-157.69%-444.12%-108.33%
EPS (Diluted)-0.80-1.02-0.16-1.13-1.28-1.00-1.17-5.35-1.84-2.71-3.94-1.53
EPS Growth %37.5%-2%86.32%78.88%30.43%63.1%70.3%-249.67%1.08%-2610%-479.41%-406%
EPS (Basic)-0.80-1.02-0.16-1.13-1.28-1.00-1.17-5.35-1.84-2.71-3.94-1.53
Diluted Shares Outstanding49.8M49.28M49.6M49.54M48.35M47.75M47.67M47.5M46.82M50.86M47.01M49.04M